Retractable Technologies Inc. (RVP)
RVP trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/946563/000110465926036053/0001104659-26-036053-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | RVP on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2001 |
| SEC CIK | 0000946563 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | TX |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $38.3M |
| Net income | -$12.6M |
| Operating income | -$21.2M |
| Net margin | -32.8% |
| Operating margin | -55.3% |
| Revenue growth | +15.8% |
| Cash | $2.6M |
| Total assets | $142.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-14 |
| Cash and burn | $2.6M cash; operating cash flow -$1.2M a quarter. | Report 2026-06-30 |
| Shares outstanding | 29,937,159 (2026-08-01); 29,937,159 a year earlier; 29,937,159 three years earlier. | Cover page 2026-08-01 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Baker Tilly US, LLP, Dallas, Texas, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-06-06 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $139K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $7.2M | $2.8M | -$1.7M | $2.6M | $379K | $33.9M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $7.2M | -$4.2M | -$1.4M | $2.8M | $372K | $37.1M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $9.4M | -$2.3M | -$597K | $2.6M | $896K | $38.3M | 10-K 2026-03-27 |
| Q3 2025 2025-09-30 | $10.1M | $371K | -$1.3M | $3.4M | $983K | $37.9M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $10.4M | -$87K | -$3.7M | $3.0M | $1.1M | $38.2M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $8.3M | -$10.5M | -$1.5M | $3.4M | $1.2M | $33.7M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $9.1M | $3.8M | -$1.1M | $4.2M | $1.2M | $33.0M | 10-K 2026-03-27 |
| Q3 2024 2024-09-30 | $10.3M | -$1.9M | -$5.7M | $3.9M | $1.3M | $38.3M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-03-27 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report FORM 8-K | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-03-27 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.8% |
| 1 month | -8.2% |
| 3 months | -17.6% |
| Year to date | -27.3% |
| 1 year | -30.9% |
| From 52-week high | -32.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CVRX | CVRx Inc. | $0.6130 | +0.92% | $17.5M |
| PMI | Picard Medical Inc. | $7.24 | +0.14% | $17.8M |
| SNWV | SANUWAVE Health Inc. | $1.81 | -0.55% | $15.6M |
| MODD | Modular Medical Inc. | $1.91 | -3.05% | $18.1M |
| CTSO | Cytosorbents Corporation | $4.85 | -0.41% | $15.3M |
| PAVM | PAVmed Inc. | $1.75 | +7.36% | $14.0M |
| GUTS | Fractyl Health Inc. | $0.9918 | +9.76% | $13.2M |
| DRIO | DarioHealth Corp. | $1.15 | -8.73% | $13.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier